赵家良教授丨从视觉损伤原因的变化看我国眼健康的进展

2019-09-05 Fiona MedSci原创

2019年9月5日,由中华医学会主办的第二十四次全国眼科学术大会在苏州拉开帷幕,梅斯医学小编也第一时间奔赴现场,为大家带来学术报道。我国“十三五”眼健康规划强调:“眼健康是国民健康的中药组成部分,包括盲在内的视觉损伤严重影响人民群众的身体健康和生活质量,加重家庭和社会负担,威胁社会经济生产活动,是涉及民生的重大公共卫生问题和社会问题。”本次大会上,中国医学科学院北京协和医院的赵家良教授为大家详细讲


2019年9月5日,由中华医学会主办的第二十四次全国眼科学术大会在苏州拉开帷幕,梅斯医学小编也第一时间奔赴现场,为大家带来学术报道。

我国“十三五”眼健康规划强调:“眼健康是国民健康的重要组成部分,包括盲在内的视觉损伤严重影响人民群众的身体健康和生活质量,加重家庭和社会负担,威胁社会经济生产活动,是涉及民生的重大公共卫生问题和社会问题。”

本次大会上,中国医学科学院北京协和医院的赵家良教授为大家详细讲解了我国眼健康的进展。

目前,对于我们国家来说眼健康的重点主要是什么呢?我们需要进行眼病调查,了解我国农村地区(50岁及以上)成人中盲和视觉损伤的主要原因。

根据2006年级2014年全国九省眼病调查资料显示,我国盲和VI患病率为



不同年龄人群中盲和视觉损伤患病率:


除此之外,近年来随着医疗水平的提高,我国居民因各种原因视觉损伤的患病率也有所下降,包括屈光不正、白内障、弱视及青光眼等。

然而,我国视网膜病的患病率(如黄斑变性、视网膜脱离等)却有所提高。总视网膜疾病发病率从2006年的2.25%升高到2014年的2.81%。

在所有眼损伤原因中,屈光不正最为普遍,也就是咱们平常所说的近视、远视及散光等,占比近50%。除此之外,白内障占比最高,为35%左右。而视网膜病约占9%左右。

视觉损伤较好眼PVA的多元回归OR值(1)

由此可见,随着年龄上升,发病率逐渐上升;而且女性比男性更易患这几类眼科疾病。

视觉损伤较好眼PVA的多元回归OR值(2)


与2006年相比,我国未手术白内障患者明显减少,但视网膜疾病显著增加。



赵家良教授总结道,
 

更多精彩内容,请持续关注梅斯医学!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2007250, encodeId=42e0200e2502a, content=<a href='/topic/show?id=63af9085083' target=_blank style='color:#2F92EE;'>#视觉损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90850, encryptionId=63af9085083, topicName=视觉损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Wed Jul 15 19:58:00 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397825, encodeId=74da139e8254f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481124, encodeId=65e9148112486, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372317, encodeId=ad0b3e2317e0, content=精彩分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160906/IMG57CE2FEB173B51358.jpg, createdBy=efbf97815, createdName=chenxh201314, createdTime=Thu Sep 05 16:37:29 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372315, encodeId=549f3e2315d6, content=有错别字哦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Thu Sep 05 15:30:59 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2007250, encodeId=42e0200e2502a, content=<a href='/topic/show?id=63af9085083' target=_blank style='color:#2F92EE;'>#视觉损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90850, encryptionId=63af9085083, topicName=视觉损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Wed Jul 15 19:58:00 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397825, encodeId=74da139e8254f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481124, encodeId=65e9148112486, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372317, encodeId=ad0b3e2317e0, content=精彩分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160906/IMG57CE2FEB173B51358.jpg, createdBy=efbf97815, createdName=chenxh201314, createdTime=Thu Sep 05 16:37:29 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372315, encodeId=549f3e2315d6, content=有错别字哦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Thu Sep 05 15:30:59 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2007250, encodeId=42e0200e2502a, content=<a href='/topic/show?id=63af9085083' target=_blank style='color:#2F92EE;'>#视觉损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90850, encryptionId=63af9085083, topicName=视觉损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Wed Jul 15 19:58:00 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397825, encodeId=74da139e8254f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481124, encodeId=65e9148112486, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372317, encodeId=ad0b3e2317e0, content=精彩分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160906/IMG57CE2FEB173B51358.jpg, createdBy=efbf97815, createdName=chenxh201314, createdTime=Thu Sep 05 16:37:29 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372315, encodeId=549f3e2315d6, content=有错别字哦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Thu Sep 05 15:30:59 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
    2019-09-07 zywlvao
  4. [GetPortalCommentsPageByObjectIdResponse(id=2007250, encodeId=42e0200e2502a, content=<a href='/topic/show?id=63af9085083' target=_blank style='color:#2F92EE;'>#视觉损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90850, encryptionId=63af9085083, topicName=视觉损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Wed Jul 15 19:58:00 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397825, encodeId=74da139e8254f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481124, encodeId=65e9148112486, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372317, encodeId=ad0b3e2317e0, content=精彩分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160906/IMG57CE2FEB173B51358.jpg, createdBy=efbf97815, createdName=chenxh201314, createdTime=Thu Sep 05 16:37:29 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372315, encodeId=549f3e2315d6, content=有错别字哦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Thu Sep 05 15:30:59 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
    2019-09-05 chenxh201314

    精彩分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2007250, encodeId=42e0200e2502a, content=<a href='/topic/show?id=63af9085083' target=_blank style='color:#2F92EE;'>#视觉损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90850, encryptionId=63af9085083, topicName=视觉损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Wed Jul 15 19:58:00 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397825, encodeId=74da139e8254f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481124, encodeId=65e9148112486, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Sep 07 05:58:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372317, encodeId=ad0b3e2317e0, content=精彩分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160906/IMG57CE2FEB173B51358.jpg, createdBy=efbf97815, createdName=chenxh201314, createdTime=Thu Sep 05 16:37:29 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372315, encodeId=549f3e2315d6, content=有错别字哦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Thu Sep 05 15:30:59 CST 2019, time=2019-09-05, status=1, ipAttribution=)]
    2019-09-05 Midas

    有错别字哦……

    0

相关资讯

绍兴首批“三焦点屈光白内障老视矫正手术示范基地”落户爱尔眼科

2019年5月18日,绍兴首批“三焦点屈光白内障手术示范基地”以及“老视矫正手术示范基地”在绍兴爱尔眼科医院正式成立。作为爱尔眼科集团布局长三角区域的重要分支,绍兴爱尔眼科携手卡尔蔡司集团引入久经临床考验、领先国际的三焦点人工晶体,为其三周年庆典献上厚礼的同时也迈出实践个性化精准诊疗的坚实一步,深入落实集团建设眼健康生态圈的国际化战略。 绍兴爱尔眼科医院CEO周杰(右)与蔡司人工晶体全国销售支持

Graefes Arch Clin Exp Ophthalmol:人体晶状体对环境辐射的光毒性综述-重新审视紫外线诱发白内障的发病机制

伊朗大不里士医科大学眼科研究中心的Kamari F等人在 Graefes Arch Clin Exp Ophthalmol杂志上发表了一篇综述文章,对人体晶状体对环境辐射的光毒性进行了综述,重新审视了紫外线诱发白内障的发病机制。

影响白内障手术后视觉效果的因素有哪些?

眼科手术医生和患者一样,最关心的问题,就是术后视觉效果。所以对待手术的每一个细节,我都非常严苛,力求最好。也有很多患者在术前甚至躺到了手术台上,还一直反复问我:医生医生,我术后视力能恢复到多少?

先天性白内障的成因和治疗方法

很多人认为白内障是老年人的专利,其实不能排除小孩、青年人患上白内障的可能性,白内障类型有多种,除了最为常见的老年性白内障以外,还有小儿先天性白内障及外伤性白内障等。

国际盲人日:白内障是失明首要病因 手术治疗理想

10月15日是国际盲人日,目前我国有1731万视力障碍残疾人。专家表示,我国约有500万盲人,白内障是致失明首要病因,比例高达40%以上,通过有效的手术治疗,这些患者都有可能复明。白内障、青光眼、年龄相关性黄斑变性、角膜混浊以及糖尿病视网膜病变等都可能造成失明,而WHO指出,目前全球80%的盲人通过有效的预防和治疗都可以脱盲。北京同仁医院眼科研究所副所长胡爱莲曾在接受健康时报记者采访时表示,眼病

三焦点屈光白内障手术、老视矫正手术示范基地落户北京爱尔

2018年11月17日,“三焦点屈光白内障手术示范基地”及“三焦点老视矫正手术示范基地”在北京爱尔英智眼科医院成立。作为北京地区首批引入三焦点人工晶体技术的非公医疗机构代表,北京爱尔将此技术与其深厚诊疗经验以及国际化的医疗资源及服务水平相结合,旨在为北京及周边地区民众带来更高水平的眼部健康解决方案,造福于民。“屈光白内障及老视矫正手术疑难杂症研讨会”同期举办,苏州大学附属第二医院眼科徐国旭主任、北